BIOSCIENCE VALUATION
Our Services & Solutions
We offer all services and analytics required to evaluate life science assets.
Commercial Assessments & Pharmacoeconomics
Bioscience Valuation’s Assessment of Commercial Opportunity covers
- in-depth analysis of disease market, standard of care and medical need,
- definition of target product profile (TPP),
- forecast of incidence and prevalence,
- detailed analysis of competitors (launched and in development),
- a pharmacoeconomic assessment,
- determination of a product’s optimal price range and likely market share,
- if required, primary market research,
- sales forecast until patent expiry
An early Pharmacoeconomic Assessment
- determines a drug’s incremental cost – effectiveness ratio (ICER) based on its TPP,
- shows whether a TPP needs improvement to ensure cost – effectivness,
- supports management in determining a drug’s market price that will likely get reimbursed.